Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 15, 2023

SELL
$154.26 - $198.1 $113,998 - $146,395
-739 Reduced 33.99%
1,435 $241,000
Q4 2022

Feb 14, 2023

BUY
$162.42 - $220.56 $140,655 - $191,004
866 Added 66.21%
2,174 $368,000
Q3 2022

Nov 10, 2022

BUY
$160.42 - $256.21 $5,454 - $8,711
34 Added 2.67%
1,308 $245,000
Q2 2022

Aug 11, 2022

SELL
$140.68 - $188.02 $47,127 - $62,986
-335 Reduced 20.82%
1,274 $207,000
Q1 2022

May 12, 2022

SELL
$161.19 - $257.96 $66,410 - $106,279
-412 Reduced 20.39%
1,609 $303,000
Q4 2021

Feb 14, 2022

SELL
$247.59 - $304.47 $24,759 - $30,447
-100 Reduced 4.71%
2,021 $535,000
Q3 2021

Nov 16, 2021

BUY
$194.77 - $324.21 $11,101 - $18,479
57 Added 2.76%
2,121 $613,000
Q2 2021

Aug 13, 2021

SELL
$165.87 - $220.95 $2,322 - $3,093
-14 Reduced 0.67%
2,064 $412,000
Q1 2021

May 17, 2021

SELL
$180.37 - $226.26 $35,713 - $44,799
-198 Reduced 8.7%
2,078 $404,000
Q4 2020

Feb 17, 2021

BUY
$148.08 - $206.57 $14,808 - $20,657
100 Added 4.6%
2,276 $436,000
Q2 2020

Aug 13, 2020

SELL
$94.33 - $140.48 $40,278 - $59,984
-427 Reduced 16.4%
2,176 $269,000
Q3 2019

Nov 06, 2019

SELL
$76.65 - $95.51 $3,219 - $4,011
-42 Reduced 1.59%
2,603 $200,000
Q2 2019

Aug 12, 2019

BUY
$54.2 - $85.95 $143,359 - $227,337
2,645 New
2,645 $228,000

Others Institutions Holding RGEN

About REPLIGEN CORP


  • Ticker RGEN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 55,491,200
  • Market Cap $7.71B
  • Description
  • Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....
More about RGEN
Track This Portfolio

Track Cetera Advisors LLC Portfolio

Follow Cetera Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cetera Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cetera Advisors LLC with notifications on news.